Ia antigen expression by human malignant lymphomas: Correlation with conventional lymphoid markers Academic Article uri icon

Overview

MeSH Major

  • Histocompatibility Antigens
  • Lymphoma
  • Receptors, Antigen, B-Cell
  • Rosette Formation

abstract

  • The Ia (p23,30) antigens are useful in determing the B- or T-cell origin of normal peripheral blood lymphocytes. However, exceptions to the preferential B-cell expression of Ia antigens exist, i.e., many plasma cells are la - and T cells are rarely la +. Therefore, the authors investigated Ia expression (assayed by direct immunofluorescence using the heteroantisera) by cells isolated from 33 malignant lymphomas and 7 benign lymph nodes. This was compared with surface immunoglobulin (Slg) and sheep erythrocyte (SRBC) receptor (E rosette) expression. Results with normal lymph nodes were similar to those described for peripheral blood. Most lymph node B cells were Ia +Slg +. Occasional Ia +Slg - B cells and rare Ia + T cells were present. Ia antigens were expressed in parallel with Slg in 15 of 19 B-cell lymphomas. In 4 B-cell lymphomas, substantial numbers of neoplastic Ia +Slg - cells were also present, suggesting the presence of neoplastic cells at varying stages of differentiation. Heterogeneity was also seen in those lymphomas associated with monoclonal proteins, as small numbers of Ia + and Ia - plasma cells were present. Seven cases expressed the T-cell (Ia -Slg -E +) phenotype. The common acute lymphoblastic leukemia phenotype (Ia +Slg -E -) was rarely expressed and may be uncommon among lymphomas. Three lymphomas expressing the Ia +E + phenotype were shown to be B-cell malignancies whose Slg had SRBC specificity. One Ia + T-cell lymphoproliferative disorder was found. Thus, Ia antigens are useful B-cell markers in most instances. Furthermore, their enumeration allows the demonstration of phenotype heterogeneity in B-cell malignancies, analogous to that described for T-cell malignancies.

publication date

  • January 1980

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 6766752

Additional Document Info

start page

  • 373

end page

  • 82

volume

  • 55

number

  • 3